Todd Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-16,767
| Closed | -$771K | – | 207 |
|
|
2020
Q4 | $771K | Sell |
16,767
-149
| -0.9% | -$6.84K | 0.02% | 180 |
|
|
2020
Q3 | $796K | Sell |
16,916
-966
| -5% | -$48.4K | 0.02% | 178 |
|
|
2020
Q2 | $912K | Hold |
17,882
| – | – | 0.03% | 179 |
|
|
2020
Q1 | $847K | Buy |
17,882
+50
| +0.3% | +$2.67K | 0.03% | 173 |
|
|
2019
Q4 | $1.05M | Sell |
17,832
-359
| -2% | -$20K | 0.03% | 179 |
|
|
2019
Q3 | $971K | Sell |
18,191
-56,782
| -76% | -$2.92M | 0.03% | 192 |
|
|
2019
Q2 | $3.75M | Buy |
74,973
+2,386
| +3% | +$120K | 0.1% | 151 |
|
|
2019
Q1 | $3.79M | Buy |
72,587
+55,234
| +318% | +$2.76M | 0.11% | 147 |
|
|
2018
Q4 | $829K | Buy |
17,353
+2,311
| +15% | +$114K | 0.03% | 185 |
|
|
2018
Q3 | $755K | Sell |
15,042
-392
| -3% | -$19.9K | 0.02% | 194 |
|
|
2018
Q2 | $777K | Hold |
15,434
| – | – | 0.02% | 191 |
|
|
2018
Q1 | $754K | Buy |
15,434
+268
| +2% | +$12.5K | 0.02% | 193 |
|
|
2017
Q4 | $673K | Sell |
15,166
-503
| -3% | -$23.2K | 0.02% | 190 |
|
|
2017
Q3 | $795K | Sell |
15,669
-1,730
| -10% | -$87.8K | 0.02% | 187 |
|
|
2017
Q2 | $938K | Buy |
17,399
+117
| +0.7% | +$6.24K | 0.03% | 189 |
|
|
2017
Q1 | $910K | Buy |
17,282
+392
| +2% | +$19.9K | 0.03% | 190 |
|
|
2016
Q4 | $813K | Buy |
16,890
+2,084
| +14% | +$103K | 0.02% | 193 |
|
|
2016
Q3 | $798K | Hold |
14,806
| – | – | 0.02% | 188 |
|
|
2016
Q2 | $802K | Sell |
14,806
-705
| -5% | -$37.1K | 0.03% | 185 |
|
|
2016
Q1 | $786K | Sell |
15,511
-1,079
| -7% | -$53.7K | 0.02% | 193 |
|
|
2015
Q4 | $837K | Sell |
16,590
-2,898
| -15% | -$148K | 0.03% | 191 |
|
|
2015
Q3 | $936K | Buy |
19,488
+1,194
| +7% | +$62.2K | 0.03% | 196 |
|
|
2015
Q2 | $953K | Sell |
18,294
-144
| -0.8% | -$8.11K | 0.03% | 203 |
|
|
2015
Q1 | $1.06M | Buy |
18,438
+680
| +4% | +$39K | 0.03% | 193 |
|
|
2014
Q4 | $949K | Sell |
17,758
-605
| -3% | -$33.8K | 0.03% | 192 |
|
|
2014
Q3 | $1.05M | Buy |
18,363
+1,535
| +9% | +$94.1K | 0.03% | 191 |
|
|
2014
Q2 | $1.13M | Buy |
16,828
+270
| +2% | +$18.3K | 0.03% | 192 |
|
|
2014
Q1 | $1.11M | Buy |
16,558
+795
| +5% | +$53.7K | 0.03% | 171 |
|
|
2013
Q4 | $1.05M | Buy |
15,763
+5,419
| +52% | +$351K | 0.03% | 169 |
|
|
2013
Q3 | $649K | Buy |
10,344
+536
| +5% | +$34.5K | 0.02% | 181 |
|
|
2013
Q2 | $613K | Buy |
+9,808
| New | +$623K | 0.02% | 204 |
|
Other funds holding GSK
BCIM
Todd Asset Management's GSK Position: Q1 2021 in Review
Todd Asset Management sold out of GSK (GSK) in Q1 2021, closing a stake of 16,767 shares — an estimated $771K sold.
Todd Asset Management first reported a position in GSK in Q2 2013 and held it in 31 quarters. The position peaked at $3.79M in Q1 2019. 774 funds tracked by Wall St. Rank hold GSK as of Q1 2021.
- Todd Asset Management reported no remaining GSK position as of Q1 2021 after selling out during the quarter.
- Todd Asset Management sold 16,767 GSK shares in Q1 2021, an estimated $771K.
- Todd Asset Management first reported a position in GSK in Q2 2013 and held it in 31 quarters.
- Todd Asset Management's GSK position peaked at $3.79M in Q1 2019.
- 774 funds tracked by Wall St. Rank held GSK as of Q1 2021.
Based on Todd Asset Management's 13F filing for Q1 2021, filed 6 May 2021.